Themis Medicare informs about updates on litigation

27 Jul 2019 Evaluate

Themis Medicare has informed that in relation to a litigation related to a key product of the Company wherein the Honble Delhi High Court vide its order dated July 5, 2018 had dismissed the Companys petition and on which the Company had preferred an appeal at the division bench of the Honble Delhi High court against the final order of the single judge. The Companys appeal has been admitted in the court. Hence, the matter is now subjudice.This may be taken as a disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015. The Company will keep the Stock Exchange informed of any further developments in this matter.

The above information is a part of company’s filings submitted to BSE.

Themis Medicare Share Price

105.60 -0.70 (-0.66%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×